Literature DB >> 12496534

Cohort study of surgical bypass to the gallbladder or bile duct for the palliation of jaundice due to pancreatic cancer.

David R Urbach1, Chaim M Bell, Lee L Swanstrom, Paul D Hansen.   

Abstract

OBJECTIVE: To compare patterns in mortality and the use of subsequent biliary drainage interventions (surgical, endoscopic, and percutaneous) associated with the different types of biliary bypass. SUMMARY BACKGROUND DATA: Surgical palliation of obstructive jaundice due to pancreatic cancer is often accomplished with an intestinal bypass to either the gallbladder or the bile duct. It is not known whether a gallbladder bypass, which is a simpler operation and more amenable to laparoscopic surgery, performs as well as a bypass to the bile duct.
METHODS: The authors conducted a retrospective cohort study of 1,919 patients 65 years of age or older who had a surgical biliary bypass for pancreatic cancer diagnosed between 1991 and 1996 using Medicare claims data and the Surveillance, Epidemiology and End Results (SEER) database.
RESULTS: At 1, 2, and 5 years, 7.5%, 17.4%, and 26.0% of 945 patients initially treated with a gallbladder bypass had additional biliary interventions, as compared with 2.9%, 11.0%, and 13.3% of 974 patients initially treated with a bile duct bypass. Patients who initially had a gallbladder bypass were 4.4 times as likely to have additional biliary surgery and 2.9 times as likely to have any subsequent biliary intervention as were patients who initially had a bile duct bypass. Median survival was longer following bile duct bypass. The adjusted hazard ratio for death associated with gallbladder bypass was 1.2.
CONCLUSIONS: Compared to patients whose initial biliary bypass was to the bile duct, the risk of having one or more additional surgical, endoscopic, or percutaneous biliary drainage procedures is substantially greater in patients whose initial bypass was to the gallbladder.

Entities:  

Mesh:

Year:  2003        PMID: 12496534      PMCID: PMC1513963          DOI: 10.1097/00000658-200301000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

Review 2.  Pancreatic carcinoma.

Authors:  A L Warshaw; C Fernández-del Castillo
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

3.  Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial.

Authors:  H A Shepherd; G Royle; A P Ross; A Diba; M Arthur; D Colin-Jones
Journal:  Br J Surg       Date:  1988-12       Impact factor: 6.939

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  The influence of hospital volume on survival after resection for lung cancer.

Authors:  P B Bach; L D Cramer; D Schrag; R J Downey; S E Gelfand; C B Begg
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

6.  Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice.

Authors:  J R Andersen; S M Sørensen; A Kruse; M Rokkjaer; P Matzen
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

7.  Laparoscopy in the management of pancreatic cancer: endoscopic cholecystojejunostomy for advanced disease.

Authors:  S Shimi; S Banting; A Cuschieri
Journal:  Br J Surg       Date:  1992-04       Impact factor: 6.939

Review 8.  Surgical palliation for pancreatic cancer: developments during the past two decades.

Authors:  P Watanapa; R C Williamson
Journal:  Br J Surg       Date:  1992-01       Impact factor: 6.939

9.  A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenterostomy.

Authors:  I J Sarfeh; E B Rypins; J G Jakowatz; G L Juler
Journal:  Am J Surg       Date:  1988-03       Impact factor: 2.565

10.  Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice.

Authors:  A G Speer; P B Cotton; R C Russell; R R Mason; A R Hatfield; J W Leung; K D MacRae; J Houghton; C A Lennon
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

View more
  13 in total

Review 1.  A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Authors:  Til Stürmer; Manisha Joshi; Robert J Glynn; Jerry Avorn; Kenneth J Rothman; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

Review 2.  Surgical palliation in patients with pancreatic cancer.

Authors:  Jörg Köninger; Moritz N Wente; Michael W Müller; Carsten N Gutt; Helmut Friess; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2006-11-11       Impact factor: 3.445

Review 3.  [Palliative bypass surgery].

Authors:  A Wojtyczka; T Moesta; C Kuntz; T Lehnert
Journal:  Chirurg       Date:  2006-03       Impact factor: 0.955

4.  Surgical palliation of unresectable pancreatic head cancer in elderly patients.

Authors:  Sang Il Hwang; Hyung Ook Kim; Byung Ho Son; Chang Hak Yoo; Hungdai Kim; Jun Ho Shin
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

Review 5.  Role of the laparoscopic approach to biliary bypass for benign and malignant biliary diseases: a systematic review.

Authors:  Zaher Toumi; Moayad Aljarabah; Basil J Ammori
Journal:  Surg Endosc       Date:  2011-02-07       Impact factor: 4.584

6.  Surgical selection for late pancreatic head carcinoma without gastric outlet obstruction.

Authors:  Shu-Hua Zhang; Juan Wang; Chong Yang; Bo Wang; He-Shui Wu; Chun-You Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

7.  Palliative surgical bypass for pancreatic and peri-ampullary cancers.

Authors:  Samrat Mukherjee; Hemant M Kocher; Robert R Hutchins; Satyajit Bhattacharya; Ajit T Abraham
Journal:  J Gastrointest Cancer       Date:  2007

8.  Androgen-deprivation therapy and risk for biliary disease in men with prostate cancer.

Authors:  Philip J Saylor; Matthew R Smith; A James O'Malley; Nancy L Keating
Journal:  Eur Urol       Date:  2013-02-12       Impact factor: 20.096

Review 9.  Laparoscopic pancreatic surgery: what now and what next?

Authors:  Elizabeth A Warner; Kfir Ben-David; Juan C Cendan; Kevin E Behrns
Journal:  Curr Gastroenterol Rep       Date:  2009-04

10.  The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life.

Authors:  N Tjarda Van Heek; Steve M M De Castro; Casper H van Eijck; Rutger C I van Geenen; Eric J Hesselink; Paul J Breslau; T C Khe Tran; Geert Kazemier; Mechteld R M Visser; Olivier R C Busch; Hugo Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.